Your browser is no longer supported. Please, upgrade your browser. Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MELA [NASD]
MELA Sciences, Inc.
Index- P/E- EPS (ttm)-4.23 Insider Own1.31% Shs Outstand6.06M Perf Week-1.18%
Market Cap10.18M Forward P/E- EPS next Y-1.30 Insider Trans12.79% Shs Float5.97M Perf Month-13.85%
Income-19.40M PEG- EPS next Q0.67 Inst Own25.30% Short Float7.98% Perf Quarter-23.64%
Sales0.60M P/S16.97 EPS this Y17.90% Inst Trans58.68% Short Ratio12.98 Perf Half Y-56.92%
Book/sh1.36 P/B1.24 EPS next Y54.70% ROA-135.90% Target Price4.50 Perf Year-76.00%
Cash/sh0.69 P/C2.42 EPS next 5Y25.00% ROE-241.70% 52W Range1.52 - 8.90 Perf YTD-73.75%
Dividend- P/FCF- EPS past 5Y11.00% ROI-291.60% 52W High-81.12% Beta0.01
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin- 52W Low10.53% ATR0.12
Employees45 Current Ratio1.60 Sales Q/Q100.00% Oper. Margin- RSI (14)45.95 Volatility5.16% 6.38%
OptionableYes Debt/Eq0.00 EPS Q/Q107.00% Profit Margin- Rel Volume1.43 Prev Close1.67
ShortableYes LT Debt/Eq0.00 EarningsNov 12 Payout- Avg Volume36.68K Price1.68
Recom2.00 SMA20-4.08% SMA50-7.99% SMA200-55.51% Volume52,333 Change0.60%
Aug-18-14Initiated H.C. Wainwright Buy $4.50
Sep-24-12Upgrade WBB Securities Hold → Speculative Buy $2 → $4
Nov-02-11Reiterated Needham Buy $14 → $20
Nov-17-10Upgrade WBB Securities Sell Short → Hold $5 → $2
Sep-10-10Initiated BioLogic Equity Research Sell
May-11-10Downgrade Brean Murray Buy → Hold
Mar-31-10Initiated Brean Murray Buy $9
Mar-25-10Downgrade WBB Securities Sell → Sell Short $7.25 → $5
Mar-25-10Downgrade Roth Capital Hold → Sell $12 → $4
Nov-30-09Initiated WBB Securities Sell $7.25
Nov-12-09Initiated Boenning & Scattergood Outperform $12.50
Oct-28-09Downgrade Roth Capital Buy → Hold $9 → $12
Aug-18-09Initiated Oppenheimer Outperform $11
Feb-13-09Initiated Caris & Company Buy $9
May-13-08Reiterated Jesup & Lamont Buy $8 → $9.50
Mar-19-08Initiated Jesup & Lamont Buy $8
Nov-19-14 04:53PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
08:00AM  MELA Sciences Names Michael R. Stewart Its Next President and CEO GlobeNewswire
Nov-18-14 07:07PM  10-Q for MELA Sciences, Inc. Company Spotlight
Nov-14-14 06:03AM  MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report EDGAR Online
Nov-12-14 04:30PM  MELA Sciences Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  MELA Sciences Reports Third Quarter 2014 Financial Results GlobeNewswire
07:07AM  Q3 2014 MELA Sciences Earnings Release - Time Not Supplied CCBN
Nov-05-14 08:00AM  MELA Sciences to Report Third Quarter 2014 Financial Results on Wednesday, November 12 GlobeNewswire
Oct-21-14 08:00AM  Outcomes Study Reports Use of MelaFind Reduced Benign Biopsies by 61% in Patients at Risk for Melanoma GlobeNewswire +16.22%
Sep-15-14 08:00AM  MELA Sciences to Provide Corporate Overview at the Craig-Hallum Capital Group's 2014 Alpha Select Conference GlobeNewswire
Sep-08-14 12:04PM  MELA Sciences to Provide Corporate Overview at the Rodman & Renshaw 16th Annual Global Investment Conference GlobeNewswire
Aug-26-14 08:00AM  MELA Sciences Collaborates With Columbia University Imaging Experts GlobeNewswire
Aug-23-14 01:04PM  MELA SCIENCES, INC. /NY Financials EDGAR Online Financials
Aug-18-14 09:12AM  UPDATE: H.C. Wainwright & Co. Initiates Coverage On MELA Sciences On Commercialization Strategy Change Benzinga
07:25AM  Coverage initiated on MELA Sciences by H.C. Wainwright Briefing.com
Aug-14-14 04:04PM  MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report EDGAR Online -7.29%
Aug-13-14 04:30PM  MELA Sciences Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:01PM  MELA Sciences Reports Second Quarter 2014 Financial Results and Provides a Business Update GlobeNewswire
07:07AM  Q2 2014 MELA Sciences Earnings Release - After Market Close CCBN
Aug-07-14 08:00AM  MELA Sciences to Host Analyst Meeting and Webcast on Wednesday, August 13 in New York City GlobeNewswire
Aug-06-14 06:02AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Financial Statements and Exhibits EDGAR Online
Aug-05-14 08:00AM  MELA Sciences Names Michael R. Stewart to Board of Directors GlobeNewswire
Aug-04-14 04:01PM  MELA Sciences to Report Second Quarter 2014 Financial Results on Wednesday, August 13 GlobeNewswire
Jul-29-14 11:52AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -6.57%
08:00AM  MELA Sciences Regains Compliance With NASDAQ Listing Requirements GlobeNewswire
Jul-25-14 07:03PM  MELA Sciences Reports the Closing of Its Private Placement GlobeNewswire
Jul-24-14 08:00AM  MELA Sciences Announces New Study Results Demonstrating Improved Diagnostic Accuracy for Resident Dermatologists When Utilizing MelaFind Predictive Probability Information GlobeNewswire
Jul-23-14 06:08AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia EDGAR Online
Jul-22-14 09:00AM  MELA Sciences Announces $27.3 Million At The Market Private Placement of Preferred Stock, Debentures and Warrants GlobeNewswire -11.74%
Jul-10-14 04:09PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Material Modification to Rights of Security Holders, Amendments to Articl EDGAR Online
08:00AM  MELA Sciences Begins Insurance Reimbursement Process With Application for New CPT Code for the MelaFind System GlobeNewswire
07:03AM  Splits Calendar: MELA Sciences splits before market open today (1:10 ratio) Briefing.com
Jul-03-14 08:00AM  MELA Sciences Announces Pending One-for-Ten Reverse Stock Split GlobeNewswire -8.82%
Jun-03-14 08:09AM  MELA Sciences initiates study on clinical impact of MelaFind on melanoma biopsy theflyonthewall.com
08:00AM  MELA Sciences Initiates First Study to Investigate Real-World Clinical Impact of the MelaFind System on Melanoma Biopsy Decision GlobeNewswire
May-16-14 04:11PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
May-14-14 04:11PM  MELA SCIENCES, INC. /NY Files SEC form 10-Q, Quarterly Report EDGAR Online -15.38%
May-13-14 06:52PM  MELA Sciences' (MELA) CEO Rose Crane on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  MELA Sciences Q1 2014 Call scheduled for 4:30 pm ET today CCBN
04:14PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E EDGAR Online
04:01PM  MELA Sciences Reports Its First Quarter 2014 Business and Financial Results Marketwired
07:07AM  Q1 2014 MELA Sciences Earnings Release - After Market Close CCBN
May-08-14 08:37AM  MELA Sciences Predictive Probability Study Supports Increased Diagnostic Accuracy by Dermatologists for Melanoma Marketwired
May-07-14 05:23PM  Melanoma Diagnostic Developer, MELA Sciences, Hosts Q1 Conference Call Tuesday, May 13th at 4:30 pm ET Marketwired
Apr-30-14 08:37AM  MELA Sciences Secures Final Investigative Site and Enrolls 100+ Patients for Post-Approval Study for MelaFind┬« System Optical Melanoma Diagnostic Device Business Wire
Apr-09-14 08:46AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online +5.56%
08:23AM  Medical Diagnostic Developer MELA Sciences Appoints Senior Healthcare Finance Executive Robert W. Cook as CFO Business Wire
Apr-02-14 04:39PM  MELA SCIENCES, INC. /NY Files SEC form 8-K/A, Termination of a Material Definitive Agreement EDGAR Online
Apr-01-14 02:47PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Termination of a Material Definitive Agreement EDGAR Online
Mar-17-14 07:49PM  MELA Sciences' CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  MELA Sciences Earnings Call scheduled for 4:30 pm ET today CCBN
04:07PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Pri EDGAR Online
04:00PM  MELA Sciences Announces 2013 Fourth Quarter and Year-End Financial Results Business Wire
07:07AM  Q4 2013 MELA Sciences Earnings Release - After Market Close CCBN
Mar-14-14 07:55AM  Optical Diagnostic Developer, MELA Sciences, Appoints Veteran Medical Device Investment Banker, Samuel Navarro, as Director Business Wire -7.04%
Mar-11-14 10:35AM  MELA Sciences, Inc. (MELA) Pioneering Earlier Detection of Melanoma Is Featured in Flaherty Financial News Newsletter #41 Marketwired -7.79%
Mar-06-14 09:36AM  Dermatology Diagnostic Developer, MELA Sciences, to Host Q4 Conference Call Monday, March 17, 2014 at 4:30 pm ET Business Wire
Feb-25-14 11:03AM  Rose Crane, CEO of Melanoma Diagnostics Provider, MELA Sciences, to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW1190AM Marketwired
Feb-24-14 08:00AM  MELA Sciences receives extension to meet NASDAQ minimum bid price theflyonthewall.com
07:55AM  Melanoma Diagnostic Provider, MELA Sciences Receives 180-Day Extension to Meet NASDAQ Minimum Bid Price Business Wire
Feb-21-14 01:12PM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Feb-06-14 01:57PM  MELA Sciences' CEO Presents at SeeThruEquity Winter Microcap Investor Conference (Transcript) at Seeking Alpha +5.80%
Feb-05-14 05:15PM  MELA Sciences Completes Private Placement to Institutional Investors and MELA Sciences Directors Business Wire
Feb-03-14 07:55AM  Melanoma Diagnostic Provider, MELA Sciences Provides Details of Recent $12.45 Million Private Placement Business Wire
07:40AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc EDGAR Online
Jan-31-14 02:03PM  CORRECTING and REPLACING Melanoma Diagnostic Provider, MELA Sciences, to Raise $12.45 Million in Private Placement to Institutional Investors and MELA Sciences Directors Business Wire
09:50AM  MELA Sciences enters $12.45M in private placement at theflyonthewall.com
Jan-30-14 07:55AM  Dermatologist Highlights Medical Benefits of MelaFind Device in Aiding Melanoma Diagnosis at Most Treatable Stage Business Wire +8.70%
Jan-27-14 07:55AM  Medical Diagnostic Developer MELA Sciences to Present at SeeThruEquity Microcap Conf. Feb. 6 in NYC and to Exhibit at Maui Dermatology Conf. Jan. 26-30 Business Wire -5.80%
Jan-22-14 07:55AM  MELA Sciences Announces the Results of its Third Clinical Advisory Meeting and the Four Clinical Posters Presented at the Winter Clinical Dermatology Conference Business Wire
Jan-16-14 07:55AM  Melanoma Diagnostic Developer MELA Sciences Hosts Clinical Advisory Meeting & Exhibits Four Clinical Posters at Winter Clinical Dermatology Conference - January 17 - 22 Business Wire +7.35%
Jan-06-14 08:01AM  MELA SCIENCES, INC. /NY Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib EDGAR Online +7.69%
Jan-02-14 08:00AM  MELA Sciences Appoints Healthcare Executive Jeff ODonnell as Director and Streamlines Board to Support Refocused Go-to-Market Strategy Business Wire
Dec-09-13 12:47PM  MELA Sciences Reports Positive Reception for its Optical Melanoma Diagnostic Device at Clinical Advisory Meeting and Mount Sinai Winter Dermatology Symposium Business Wire
Dec-06-13 07:56AM  Melanoma Diagnostics Leader, MELA Sciences, Inc., Participates in Skin Cancer Diagnostic Workshop with Leading German Dermatologists, Hosted by Germanys Augsburg Clinic Business Wire
MELA Sciences, Inc., a medical device company, designs, develops, and commercializes a non-invasive point-of-care instrument to aid in the detection of melanoma. The company's principal product, MelaFind, consists of a hand-held component that emits light of multiple wavelengths to capture digital data from clinically atypical pigmented skin lesions, which is then analyzed utilizing classification algorithms trained on its proprietary database of melanomas and benign lesions to provide information to assist in the management of the patient's disease, including information useful in the decision of whether to biopsy the lesion. MELA Sciences, Inc. offers its product to dermatologists. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DIMUN ANTHONY JDirectorMay 22Buy0.3887,50033,381101,013May 27 03:20 PM
Via LuAnnDirectorFeb 05Buy0.7413,51310,00028,513Feb 06 03:29 PM
DIMUN ANTHONY JDirectorFeb 05Buy0.7413,51310,00013,513Feb 06 03:16 PM
Swintek Kathryn BDirectorFeb 05Buy0.7413,51310,00033,513Feb 06 02:58 PM
Crane Rosemary ACEO and PresidentFeb 05Buy0.7467,57050,00267,570Feb 06 12:53 PM
Coradini RobertChairmanFeb 05Buy0.7467,56750,000139,024Feb 06 12:29 PM
STONE DAVID KDirectorFeb 05Buy0.7413,51410,00023,514Feb 06 04:12 PM
ODONNELL JEFFREY FDirectorFeb 05Buy0.7413,51310,00013,513Feb 10 04:54 PM